Kwadwo Asamoah Kusi profile image

Kwadwo Asamoah Kusi

ASSOCIATE PROFESSOR

Google Scholar
Verified email at noguchi.ug.edu.gh Noguchi Memorial Institute for Medical Research, University of Ghana Google Scholar

CollegeCOLLEGE OF HEALTH SCIENCES
School / InstituteNOGUCHI MEM. INST. FOR MED.RES
DepartmentDEPARTMENT OF IMMUNOLOGY
Immunology
Publications

171

Citations

2,480

H-index

27

i10-index

56

Publication activity
Publication statistics
Average citations
14.5
Most cited paper
193
First publication year
1900
Latest publication year
2026
Last updated
13 Sep 2026, 23:00
Publications

171 matching publications

PublicationYearJournalThematic areaCitations
Plasmodium falciparum AMA1 and CSP antigen diversity in parasite isolates from southern Ghana
KA Kusi, LE Amoah, FK Acquah, NA Ennuson, AF Frempong, EA Ofori, ...
2024 Frontiers in Cellular and Infection Microbiology 14, 1375249, 2024 Health Sciences 3
Angiogenic and angiostatic factors present in the saliva of malaria patients
CE Lekpor, F Botchway, KA Kusi, AA Adjei, MD Wilson, JK Stiles, ...
2022 Malaria Journal 21 (1), 220, 2022 Health Sciences 3
The pharmacologically active alkaloid cryptolepine activates a type 1 interferon response that is independent of MAVS and STING pathways
SA Domfeh, PW Narkwa, O Quaye, KA Kusi, BS Addy, S Lant, RP Sumner, ...
2022 Journal of immunology research 2022 (1), 8873536, 2022 Health Sciences 3
Comparison of the impact of allelic polymorphisms in PfAMA1 on the induction of T Cell responses in high and low malaria endemic communities in Ghana
EA Ofori, JKA Tetteh, A Frimpong, H Ganeshan, M Belmonte, B Peters, ...
2021 Malaria Journal 20 (1), 367, 2021 Health Sciences 3
Localization and function of a Plasmodium falciparum protein (PF3D7_1459400) during erythrocyte invasion
E Amlabu, PB Nyarko, G Opoku, D Ibrahim-Dey, P Ilani, H Mensah-Brown, ...
2021 Experimental Biology and Medicine 246 (1), 10-19, 2021 Health Sciences 3
Hepatitis B infection outcome is associated with novel human leukocyte antigen variants in Ghanaian cohort
KZ Tandoh, KA Kusi, TN Archampong, I Boamah, O Quaye
2020 Experimental Biology and Medicine 245 (9), 815-822, 2020 Health Sciences 3
Reevaluating malaria severity metrics: insights from PfHRP2-derived biomass estimates in Ghanaian children
EA Konadu, AO Obese, CK Danso-Coffie, T Addison, E Kyei-Baafour, ...
2026 Malaria Journal 25 (1), 119, 2026 Health Sciences 2
Determinants of pneumococcal carriage by age in Africa (2000–2021): a systematic analysis
EM Kwesi-Maliepaard, NKDO Opoku, B Egyir, NTKD Dayie, KA Kusi, ...
2025 Frontiers in Medicine 12, 1683313, 2025 Health Sciences 2
Longitudinal evaluation of T-cell responses to Pfizer-BioNTech and Janssen SARS-CoV-2 vaccines as boosters in Ghanaian adults
F Osei, KK Tudzi, IO Othol, SP Segbefia, DA Prah, EN Armah-Vedjesu, ...
2025 Frontiers in Immunology 16, 1643083, 2025 Health Sciences 2
Antibody response to malaria vaccine candidates in pregnant women with Plasmodium falciparum and Schistosoma haematobium infections
NA Frempong, A Mama, B Adu, KA Kusi, MF Ofori, C Ahiabor, WK Anyan, ...
2024 Parasite Immunology 46 (4), e13027, 2024 Health Sciences 2
Expression patterns of immune checkpoint proteins and Plasmodium falciparum‐induced cytokines in chronic hepatitis B virus‐infected and uninfected individuals …
SP Segbefia, DA Asandem, A Pobee, B Asare, AD Prah, R Baba‐Adam, ...
2024 Health Science Reports 7 (8), e2280, 2024 Health Sciences 2
Seventh annual research meeting of the Noguchi Memorial Institute for Medical Research: malaria control and elimination.
B Abuaku, DK de Souza, E Kyei-Baafour, KA Kusi, M Ofori, ...
2024 Health Sciences 2
From research to health policy: The Noguchi story in the past, present and next 25 years
D Yeboah-Manu, JK Odoom, S Osei-Wusu, A Adoma-Boakye, ...
2023 Frontiers in Tropical Diseases 4, 1135354, 2023 Health Sciences 2
Harnessing conserved epitopes and multivalent antigen strategies for vaccine design: Lessons learned and opportunities
E Adjei-Gati, CNO Quaye, PO Lamptey, LD Oklu, JN Kwofie, YA Hafiz, ...
2026 Human Vaccines & Immunotherapeutics 22 (1), 2652680, 2026 Health Sciences 1
Population HLA coverage of experimentally characterized P. falciparum CD8+ T cell epitopes as potential components of a multi-epitope malaria vaccine construct: an in silico …
C Siame, R Abdul-Mumin, G Agyekum, L Akuffo, E Afari, CAB Yankey, ...
2026 Frontiers in Bioinformatics 6, 1722563, 2026 Health Sciences 1
Reduced COVID-19 severity in Africa: a systematic review of host genetic and immunological responses to SARS-CoV-2 infection
GP Manu, JHK Bonney, FK Bawa, PK Quashie, KA Kusi, LE Amoah
2026 Frontiers in Immunology 17, 1782808, 2026 Health Sciences 1
Anti-plasmodial and toxicological effects of BEEMAR-a natural formulation of harnessed honeycomb bioactive compounds suspended in enhanced marine plasma
S Adjei, R Obeng-Kyeremeh, I Ackah, C Agbemelo-Tsomafo, D Amoah, ...
2025 Frontiers in Natural Products 4, 1602899, 2025 Health Sciences 1
Determination of Salivary Lactoferrin Levels Before and After Non-Surgical Periodontal Treatment in Patients with Aggressive Periodontitis: Salivary Lactoferrin in Aggressive …
MNB Ayettey-Adamafio, D Tormeti, TA Ndanu, NO Nartey, KA Kusi, ...
2025 Postgraduate Medical Journal of Ghana 14 (1), 16-21, 2025 Health Sciences 1
Immunogenicity of HLA-restricted peptide vaccine candidates delivered by self-assembling protein nanoparticle (SAPN) technology
M Belmonte, KA Kusi, E Kyei-Baafour, EA Ofori, P Burkhard, E Angov, ...
2025 Vaccine 66, 127832, 2025 Health Sciences 1
Immunomodulatory effect of Moringa oleifera and Phyllanthus niruri extracts on anti-HBV cytokine production by human peripheral blood mononuclear cells
B Asare, PS Segbefia, R Awuku-Larbi, DA Asandem, T Brenko, ...
2025 Open Research Europe 5, 149, 2025 Health Sciences 1
No evidence of MMR induced trained immunity to prevent SARS COV2: results from a multi-centre RCT
S Delany-Moretlwe, HM Dehbi, I Sikazwe, G Kyei, K Koram, E Dubberke, ...
2025 Frontiers in immunology 16, 1588190, 2025 Health Sciences 1
Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults
KA Koram, KA Walker, B Orizu, I Marrero, J Boyer, SP Yang, KE Broderick, ...
2025 Frontiers in Immunology 16, 1658549, 2025 Health Sciences 1
Antenatal care attendance, intermittent preventive treatment in pregnancy, and malaria knowledge: A cross-sectional study in government and private district hospitals
C Ahiabor, D Courtin, W Anyan, A Mama, N Adjeley Frempong, KA Kusi
2024 Global Health Economics and Sustainability 2 (2), 2336, 2024 Health Sciences 1
Seventh Annual Research Meeting of the Noguchi Memorial Institute for Medical Research: Bacterial Infections and Antimicrobial Resistance
B Egyir, DK de Souza, S Osei-Wusu, J Kumi, KA Kusi, M Ofori, ...
2024 Ghana Medical Journal 58 (2), 4-6, 2024 Health Sciences 1
Corrigendum: asymptomatic malaria infection is maintained by a balanced pro-and anti-inflammatory response
A Frimpong, J Amponsah, AS Adjokatseh, D Agyemang, L Bentum-Ennin, ...
2021 Frontiers in Microbiology 12, 686435, 2021 Health Sciences 1